Publications by authors named "F N Al Hadi"

The increasing need for sustainable agricultural practices due to the overuse of chemical fertilizers has prompted interest in microalgae as biofertilizers. This review investigates the potential of microalgae as biofertilizers and phycoremediators within sustainable agroecosystems, addressing both soil fertility and wastewater management. Microalgae provide a dual benefit by absorbing excess nutrients and contaminants from wastewater, generating nutrient-rich biomass that can replace chemical fertilizers and support plant growth.

View Article and Find Full Text PDF

Endocrine therapies targeting the estrogen receptor (ER/ESR1) are the cornerstone to treat ER-positive breast cancers patients, but resistance often limits their effectiveness. Notable progress has been made although the fragmented way data is reported has reduced their potential impact. Here, we introduce EstroGene2.

View Article and Find Full Text PDF

Grapes have been widely used for dietary ailments due to their attributed pharmacological activities. Resveratrol, the chief constituent of grapes, is responsible for their pharmacological benefits. However, apart from their beneficial effects, grapes have also recently been considered in drug interaction studies.

View Article and Find Full Text PDF
Article Synopsis
  • - Hyperkalemia, a condition common in heart failure and kidney disease patients using RAAS inhibitors, complicates their treatment; new potassium binders like sodium zirconium cyclosilicate show promise for managing this issue.
  • - A panel of twelve experts from Kuwait used a modified Delphi method to reach a consensus on hyperkalemia management, resulting in 44 statements covering treatments for acute cases, heart failure, chronic kidney disease, and hemodialysis.
  • - The consensus highlights the inconsistencies in current management guidelines and aims to provide standardized guidance for healthcare practitioners in Kuwait, addressing the treatment gaps in the Arabian Gulf region.
View Article and Find Full Text PDF
Article Synopsis
  • Antipsychotic drugs can negatively affect metabolic syndrome components, leading to metabolic disturbances in patients with schizophrenia, which this study aimed to address.
  • The study involved 70 schizophrenia patients on antipsychotics, divided into two groups receiving either a synbiotic supplement or placebo for 8 weeks, measuring various health indicators before and after the intervention.
  • Results showed that the synbiotic significantly reduced waist circumference and HbA1c levels and may help prevent BMI increases in those on antipsychotics, although some measures like LDL and triglycerides showed no significant difference compared to placebo.
View Article and Find Full Text PDF